ctDNA Positivity Is Not a Treatment Indication: Defining the Actionability Threshold for Molecular Residual Disease
Post-treatment ctDNA positivity is associated with recurrence risk across solid tumors, but detecting molecular disease earlier does not necessarily identify an intervention that improves outcomes ...
Authors
- Jian Zheng
- Yong Guo
Publication Details
- Journal
- Cancer Investigation
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1080/07357907.2026.2763575
- Primary Topic
- Cancer Genomics and Diagnostics
- Type
- article
- Field-Weighted Citation Impact
- 0.00